Company profile: Ziylo
1.1 - Company Overview
Company description
- Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ziylo
Recombia
HQ: United States
Website
- Description: Provider of synthetic biology and genome engineering solutions, offering yeast strain optimization, metabolic engineering, and microbial strain engineering to enhance industrial fermentation, produce natural products, and support various industrial applications using rationally designed genetic modifications with high precision, efficiency, and throughput.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Recombia company profile →
NorthStar Medical Radioisotopes
HQ: United States
Website
- Description: Provider of radioisotopes and radiopharmaceutical CDMO/CMO services for the nuclear medicine market, producing Actinium-225 (Ac-225) and Copper-67 (Cu-67) in scalable, commercial quantities via electron beam accelerators, and delivering end-to-end contract development and manufacturing from research to commercialization, with environmentally friendly accelerator-based production of multiple isotopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthStar Medical Radioisotopes company profile →
Nanosphere
HQ: United States
Website
- Description: Provider of a nanotechnology-based molecular diagnostics platform and clinical tests for genomic and protein testing and analysis. Instruments use microfluidics to pull DNA and proteins, delivering results in hours rather than days or weeks, with sensitivity two to three times higher than common hospital lab tests and much simpler.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanosphere company profile →
ProteinSimple
HQ: United States
Website
- Description: Provider of protein tools and analysis solutions that help researchers resolve protein analysis problems to reveal insights into proteins and their role in disease; part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProteinSimple company profile →
Bio-Techne
HQ: United States
Website
- Description: Provider of tools for life science research, therapeutic manufacturing, and clinical diagnostics, including automated protein analysis (Simple Western), automated ELISA (Ella), bead-based multiplex assays (Luminex), non-viral gene transfer (TcBuster), recombinant antibodies, and custom bioactive compound libraries (Tocriscreen PRO) for research, drug discovery, and cell engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-Techne company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ziylo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ziylo
2.2 - Growth funds investing in similar companies to Ziylo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ziylo
4.2 - Public trading comparable groups for Ziylo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →